UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.56B |
| 2 |
Eaton
ETN
|
+$585M |
| 3 |
SPDR Gold Trust
GLD
|
+$582M |
| 4 |
Hewlett Packard
HPE
|
+$514M |
| 5 |
Southwest Airlines
LUV
|
+$510M |
Top Sells
| 1 |
Strategy Inc Common Stock Class A
MSTR
|
+$660M |
| 2 |
Phillips 66
PSX
|
+$549M |
| 3 |
Microsoft
MSFT
|
+$513M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
| 5 |
Boeing
BA
|
+$458M |
Sector Composition
| 1 | Technology | 19.9% |
| 2 | Financials | 12.02% |
| 3 | Healthcare | 8.45% |
| 4 | Consumer Discretionary | 8.12% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBOT
4151
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$796M
| $1.05M | ﹤0.01% |
92,660
+57,712
| +165% | +$652K |
|
4152
NB Bancorp
NBBK
$740M
| $1.05M | ﹤0.01% |
57,894
-21,762
| -27% | -$393K |
|
4153
Open Lending Corp
LPRO
$253M
| $1.04M | ﹤0.01% |
378,414
-137,860
| -27% | -$380K |
|
4154
Conduent
CNDT
$442M
| $1.04M | ﹤0.01% |
385,187
+33,435
| +10% | +$90.3K |
|
4155
-1x Short VIX Futures ETF
SVIX
$191M
| $1.04M | ﹤0.01% |
51,097
+49,097
| +2,455% | +$999K |
|
4156
PIMCO Corporate & Income Opportunity Fund
PTY
$2.67B
| $1.04M | ﹤0.01% |
71,774
+2,683
| +4% | +$38.8K |
|
4157
Central Garden & Pet
CENT
$2.28B
| $1.04M | ﹤0.01% |
28,292
-7,274
| -20% | -$267K |
|
4158
SPDR Russell 1000 Low Volatility ETF
ONEV
$588M
| $1.04M | ﹤0.01% |
8,172
+6,378
| +356% | +$809K |
|
4159
ProShares Ultra Gold
UGL
$744M
| $1.03M | ﹤0.01% |
+32,148
| New | +$1.03M |
|
4160
BRF SA
BRFS
$5.99B
| $1.03M | ﹤0.01% |
300,725
+267,749
| +812% | +$921K |
|
4161
Global X S&P 500 Catholic Values ETF
CATH
$1.05B
| $1.03M | ﹤0.01% |
15,313
+3,245
| +27% | +$219K |
|
4162
Nomura Holdings
NMR
$21.9B
| $1.03M | ﹤0.01% |
168,051
-447,846
| -73% | -$2.75M |
|
4163
Icahn Enterprises
IEP
$4.77B
| $1.03M | ﹤0.01% |
113,433
+72,075
| +174% | +$653K |
|
|
MSB
4164
Mesabi Trust
MSB
$414M
| $1.03M | ﹤0.01% |
37,711
+12,598
| +50% | +$343K |
|
4165
Southern California Bancorp
BCAL
$558M
| $1.02M | ﹤0.01% |
71,285
-302
| -0.4% | -$4.33K |
|
4166
Seres Therapeutics
MCRB
$154M
| $1.02M | ﹤0.01% |
72,808
+55,692
| +325% | +$780K |
|
|
ABVX
4167
Abivax
ABVX
$6.62B
| $1.02M | ﹤0.01% |
162,554
-12,319
| -7% | -$77K |
|
|
PMM
4168
Putnam Managed Municipal Income
PMM
$260M
| $1.01M | ﹤0.01% |
165,485
-4,235
| -2% | -$26K |
|
4169
Cohen & Steers Real Estate Opportunities and Income Fund
RLTY
$260M
| $1.01M | ﹤0.01% |
65,902
-2,861
| -4% | -$43.9K |
|
|
FT
4170
Franklin Universal Trust
FT
$200M
| $1.01M | ﹤0.01% |
133,824
+15,078
| +13% | +$114K |
|
4171
Latham Group
SWIM
$911M
| $1M | ﹤0.01% |
155,863
-130,434
| -46% | -$839K |
|
4172
Invesco S&P MidCap 400 Pure Value ETF
RFV
$275M
| $1M | ﹤0.01% |
8,775
+5,065
| +137% | +$578K |
|
|
AWF
4173
AllianceBernstein Global High Income Fund
AWF
$972M
| $1M | ﹤0.01% |
93,232
-17,591
| -16% | -$189K |
|
4174
Perspective Therapeutics
CATX
$240M
| $1M | ﹤0.01% |
469,518
-102,230
| -18% | -$218K |
|
4175
German American Bancorp
GABC
$1.53B
| $998K | ﹤0.01% |
26,600
-11,463
| -30% | -$430K |
|